Pro: Fresh versus frozen embryo transfer. Is frozen embryo transfer the future?

低温保存 胚胎移植 活产 怀孕 随机对照试验 玻璃化 胚胎冷冻保存 胚胎 更安全的 妊娠率 单胚胎移植 产科 医学 妇科 男科 生物 外科 计算机科学 遗传学 计算机安全 细胞生物学
作者
Christos Venetis
出处
期刊:Human Reproduction [Oxford University Press]
卷期号:37 (7): 1379-1387 被引量:13
标识
DOI:10.1093/humrep/deac126
摘要

Embryo cryopreservation has been an integral part of ART for close to 40 years and vitrification has boosted overall ART efficacy and safety. Recently, there has been a vivid scientific discussion on whether elective cryopreservation of all embryos (freeze-all) should be pursued for most patients, with a fresh embryo transfer taking place only in selected cases. In terms of efficacy, the available evidence suggests that the freeze-all strategy leads to higher live birth rates after the first embryo transfer compared to the conventional strategy in high responders, while there is no difference in normal responders. There is no evidence to suggest that the freeze-all strategy is inferior to the conventional strategy of fresh transfer when comparing cumulative live birth rates using data from all available randomized controlled trials. The incidence of ovarian hyperstimulation syndrome is significantly reduced in the freeze-all policy. However, regarding obstetric complications and neonatal outcomes, the evidence suggests that each strategy is associated with certain risks and, therefore, there is no approach that could be unequivocally accepted as safer. Similarly, limited evidence does not support the notion that patients would be universally against freeze-all owing to the inevitable delay in pregnancy achievement. Finally, the cost-effectiveness of freeze-all is likely to vary in different settings and there have been studies supporting that this policy can be, under certain conditions, cost-effective. Adoption of the freeze-all policy can also allow for more flexible treatment strategies that have the potential to increase efficacy, reduce cost and make treatment easier for patients and clinics. Importantly, freeze-all does not require the use of any experimental technologies, further training of personnel or the costly acquisition of new equipment. For these reasons, transitioning to the freeze-all policy for most patients appears to be the next logical step in ART.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
算命先生发布了新的文献求助10
刚刚
归尘发布了新的文献求助10
刚刚
搜集达人应助踏实映天采纳,获得10
1秒前
1秒前
2秒前
核桃小小苏完成签到,获得积分10
4秒前
5秒前
6秒前
英俊的铭应助小巧十三采纳,获得10
7秒前
ll发布了新的文献求助10
8秒前
liia发布了新的文献求助10
9秒前
BJUTyang发布了新的文献求助10
10秒前
海绵宝宝完成签到 ,获得积分10
10秒前
量子星尘发布了新的文献求助150
11秒前
发发发完成签到,获得积分10
15秒前
123完成签到,获得积分10
16秒前
16秒前
jiajiajia完成签到,获得积分20
16秒前
英姑应助LucyMartinez采纳,获得10
17秒前
葛儿完成签到 ,获得积分10
19秒前
小巧十三完成签到,获得积分10
20秒前
liia完成签到,获得积分10
23秒前
量子星尘发布了新的文献求助10
23秒前
李爱国应助戴明琪采纳,获得30
26秒前
27秒前
灰机灰机完成签到,获得积分10
27秒前
oahcchao完成签到,获得积分10
30秒前
32秒前
Zehn发布了新的文献求助10
34秒前
深情安青应助irisjlj采纳,获得10
35秒前
可爱的函函应助探索小新采纳,获得10
37秒前
37秒前
无花果应助Zehn采纳,获得10
38秒前
xsy完成签到 ,获得积分10
40秒前
caoxiwei发布了新的文献求助10
41秒前
量子星尘发布了新的文献求助10
42秒前
44秒前
46秒前
47秒前
47秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
SOFT MATTER SERIES Volume 22 Soft Matter in Foods 1000
Zur lokalen Geoidbestimmung aus terrestrischen Messungen vertikaler Schweregradienten 1000
Storie e culture della televisione 500
Selected research on camelid physiology and nutrition 500
《2023南京市住宿行业发展报告》 500
Food Microbiology - An Introduction (5th Edition) 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 4883546
求助须知:如何正确求助?哪些是违规求助? 4169043
关于积分的说明 12935786
捐赠科研通 3929327
什么是DOI,文献DOI怎么找? 2156096
邀请新用户注册赠送积分活动 1174515
关于科研通互助平台的介绍 1079202